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INTRODUCTION 
            Analytical chemistry1 is the science that seeks ever improved means of measuring the 
chemical composition of natural and artificial materials. Analytical chemistry is a sub 
discipline of chemistry that has the broad mission of understanding the chemical composition 
of all matter and developing the tools to elucidate such compositions. 
Types 
Traditionally, analytical chemistry has been split into two main types, qualitative and 
quantitative. 
Qualitative 
 Qualitative analysis seeks to establish the presence of a given element, given 
functional group or inorganic or organic compound in a sample. 
Quantitative 
 Quantitative analysis seeks to establish the amount of a given element or compound in 
a sample. 
 
METHOD DEVELOPMENT 
 
           Analytical methods development and validation play important roles in the discovery, 
development, and manufacture of pharmaceuticals. 
Pharmaceutical products formulated with more than one drug, typically referred to as 
combination products, are intended to meet previously unmet patients need by combining the 
therapeutic effects of two or more drugs in one product. These combination products can 
present daunting challenges to the analytical chemist responsible for the development and 
validation of analytical methods. This presentation will discuss the development and 
validation of analytical method (Spectrophotometric, High performance liquid 
chromatography (HPLC), & High performance thin layer chromatography for drug products 
containing more than one active ingredient. The official test methods that result from these 
processes are used by quality control laboratories to ensure the identity, purity, potency, and 
performance of drug products.  
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Introduction 
The number of drugs introduced into the market is increasing every year. These drugs may be 
either new entities or partial structural modification of the existing one. Very often there is a 
time lag from the date of introduction of a drug into the market to the date of its inclusion in 
pharmacopoeias. This happens because of the possible uncertainties in the continuous and 
wider usage of these drugs, reports of new toxicities (resulting in their withdrawal from the 
market), development of patient resistance and introduction of better drugs by competitors. 
Under these conditions, standards and analytical procedures for these drugs may not be 
available in the pharmacopoeias. It becomes necessary, therefore to develop newer analytical 
methods for such drugs.  
Basic criteria for new method development of drug analysis  
♣ The drug or drug combination may not be official in any pharmacopoeias. 
♣ A proper analytical procedure for the drug may not be available in the literature due to 
patent regulations. 
♣ Analytical methods may not be available for the drug in the form of a formulation due 
to the interference caused by the formulation excipients, 
♣ Analytical methods for the quantification of the drug in biological fluids may not be 
available, 
♣ Analytical methods for a drug in combination with other drugs may not be available, 
♣ The existing analytical procedures may require expensive reagents and solvents. It 
may also involve cumbersome extraction and separation procedures and these may 
not be reliable. 
Introduction to UV - Spectrophotometric Method of Analysis for Drugs  
 
Simultaneous estimation of drug combination is generally done by separation using 
chromatographic methods like HPLC, GC etc. These methods are accurate and precise with 
good reproducibility, but the cost of analysis is quite high owing to expensive 
instrumentation, reagent and expertise.  Hence it is worthwhile to develop simpler and cost 
effective method for simultaneous estimation of drugs for routine analysis of formulation. 
Spectrophotometric analysis fulfils such requirement where the simultaneous estimation of 
the drug combination can be done with similar effectiveness as that of chromatographic 
methods.  
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The spectrophotometric assay of drugs rarely involves the measurement of absorbance of 
samples containing only one absorbing component. The pharmaceutical analyst frequently 
encounters the situation where the concentration of one or more substances is required in 
samples known to contain other absorbing substances, which potentially interfere in the 
assay. If the formula of the samples is known, the identity and concentration of the interfering 
substance are known and the extent of interference in the assay may be determined.  
 
The basis of all the spectrophotometric techniques for multicomponent samples is the 
property that at all wavelengths 
  
♣ The absorbance of a solution is the sum of absorbance of the individual components 
or 
♣ The measured absorbance is the difference between the total absorbance of the 
solution in the sample cell and that of the solution in the reference cell. 
♣ There are various spectrophotometric methods are available which can be used for the 
analysis of a combination samples. Following methods can be used Simultaneous 
equation method 
♣ Derivative spectrophotometric method 
♣ Absorbance ratio method ( Q-Absorbance method) 
♣ Difference spectrophotometry 
♣ Solvent extraction method 
 
Simultaneous Equation Method 
 
If a sample contains two absorbing drugs (X and Y) each of which absorbs at the lmax 
of the other (as shown in figure 1. λ1 and&lambda;2), it may be possible to determine both 
drugs by the technique of simultaneous equation  (Vierodt’s method) provided that certain 
criteria apply.  
The information’s required are:  
 
• The absorptivities of X at λ1 and λ2, ax1 and ax2 respectively. 
• The absorptivities of Y at λ1 andλ2, ay1 and ay2 respectively. 
• The absorbance of the diluted sample at λ1 and λ2, A1 and A2 respectively. 
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Let Cx and Cy be the concentration of X and Y respectively in the diluted 
samples.        
 
Two equations are constructed based upon the fact that at λ1 andλ2, the absorbance of 
the mixture is the sum of the individual absorbance of X and Y.  
Cx   =   (A2 ay1 - A1 ay2) / (ax2 ay1 - ax1 ay2) 
Cy     = (A1 ax2 - A2 ax1) / (ax2 ay1 - ax1 ay2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1 the overlain spectra of substance X and Y, showing the wavelength for the Q-
Absorbance Method (Absorbance Ratio Method)  
 
Q-Absorbance method depends on the property that, for a substance which obeys 
Beer's law at all wavelength, the ratio of absorbance’s at any two wavelengths is a constant 
value independent of concentration or path length. For example, two different dilution of the 
same substance give the same absorbance ratio A1/A2. In the USP, this ratio is referred to as 
Q value.  
 
In the quantitative assay of two components in a mixture by the absorbance ratio 
method, absorbance’s are measured at two wavelengths. One being the λmax of one of the 
component (λ2) and the other being a wavelength of equal absorptivities of the two 
components (As shown in figure 2) i.e. an isoabsorptive point.  
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Fig.2 Wavelength for the assay of substances X and Y in admixture by the method of 
absorbance ratio method.  
 
Cx =    (QM - QY) A1 / (QX - QY) ax1  
Cy =    (QM – Qx) A1 / (QX - QY) ax1  
 
Above equation gives the concentration of X and Y in terms of absorbance ratios, the 
absorbance of mixture and the absorptivities of the compounds at the isoabsorptive 
wavelength.  
 
Derivative Spectroscopy  
 
For the purpose of spectral analysis in order to relate chemical structure to electronic 
transitions, and for analytical situations in which mixture contribute interfering absorption, a 
method of manipulating the spectral data is called derivative spectroscopy15.  
 
Derivative spectrophotometry involves the conversions of a normal spectrum to its 
first, second or higher derivative spectrum. In the context of derivative spectrophotometry, 
the normal absorption spectrum is referred to as the fundamental, zero order, or D0 spectrum.  
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The first derivative D1 spectrum is a plot of the rate of change of absorbance with 
wavelength against wavelength i.e. a plot of the slope of the fundamental spectrum against 
wavelength or a plot of dA/dλ vs. λ. The maximum positive and maximum negative slopes 
respectively in the D spectrum correspond with a maximum and a minimum respectively in 
the D1 spectrum. The λmax in D spectrum is a wavelength of zero slope and gives dA/dλ = 0 
in the D1 spectrum.  
 
The second derivative D2 spectrum is a plot of the curvature of the D spectrum against 
wavelength or a plot of d2A/ dλ2  vs. λ. The maximum negative curvature in the D spectrum 
gives a minimum in the D2 spectrum, and the maximum positive curvature in the D spectrum 
gives two small maxima called satellite bands in the D2 spectrum. The wavelength of 
maximum slope and zero curvature in the D spectrum correspond with cross-over points in 
the D2 spectrum.  
 
These spectral transformations confer two principal advantages on derivative 
spectrophotometry. Firstly, an eve order spectrum is of narrower spectral bandwidth than its 
fundamental spectrum.  A derivative spectrum therefore shows better resolution of 
overlapping bands than the fundamental spectrum and may permit the accurate determination 
of the λmax of the individual bands. Secondly, derivative spectrophotometry discriminates in 
favour of substances of narrow spectral bandwidth against broad bandwidth substances. All 
the amplitudes in the derivative spectrum are proportional to the concentration of the analyte, 
provided that Beer's law is obeyed by the fundamental spectrum.  
 
The second technique to generate derivative spectra is electronic differentiation of the 
spectrophotometer analog signal. Resistance capacitance (RC) modules may be incorporated 
in series between the spectrophotometer and recorder to provide differentiation of the 
absorbance, not with respect to wavelength, but with respect to time, thereby producing the 
signal dA/dt. If the wavelength scan rate is constant (dλ/dt = C), the derivative with respect 
to wavelength is given by  
dA/ dλ =  (dA/dt) / (dλ /dt) = (dA/dt)(1/C) 
 
Derivative spectra obtained by RC modules are highly dependent on instrumental 
parameters, in particular the scan speed and the time constant. It is essential, therefore, to 
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employ a standard solution of the analyte to calibrate the measured value the instrumental 
conditions selected.  
 
The third technique is based upon microcomputer differentiation. Microcomputers 
incorporated into or interfaced with the spectrophotometer may be programmed to provide 
derivative spectra during or after the scan, to measure derivative amplitudes between 
specified wavelengths and to calculate concentrations and associated statistics from the 
measured amplitude.  
 
Introduction to HPTLC Method of Analysis for Drugs 2 
 
HPTLC (High Performance Thin Layer Chromatography) is a well known and 
versatile separation method which shows a lot of advantages in comparison to other 
separation techniques.  
 
 
Layer of Sorbent  100µm  
Efficiency  High due to smaller particle size generated  
Separations  3 - 5 cm  
Analysis Time  Shorter migration distance and the analysis time is greatly  
reduced  
Solid support  Wide choice of stationary phases like silica gel for normal  
Phase and C8 , C18 for reversed phase modes  
Development chamber New type that require less amount of   mobile phase  
Sample spotting  Auto sampler  
Scanning  Use of UV/ Visible/ Fluorescence scanner scans the entire  
chromatogram qualitatively and quantitatively and the  
scanner is an advanced type of densitometer  
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Features of HPTLC 
 
1. Simultaneous processing of sample and standard - better analytical precision and less 
need for Internal Standard 
2. Several analysts work simultaneously 
3. Lower analysis time and less cost per analysis 
4. Low maintenance cost 
5. Simple sample preparation - handle samples of divergent nature 
6. No prior treatment for solvents like filtration and degassing 
7. Low mobile phase consumption per sample 
8. No interference from previous analysis - fresh stationary and mobile phases for each 
analysis - no contamination 
9. Visual detection possible - open system 
10. Non UV absorbing compounds detected by post-chromatographic derivatization 
 
 
Steps involved in HPTLC  
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Sample and Standard Preparation 
-  To avoid interference from impurities and water vapours.   
-  Low signal to noise ratio  
-  Straight base line 
- Improvement of LOD 
-  Solvents used are Methanol, Chloroform: Methanol (1:1), Ethyl acetate: Methanol 
(1:1), Chloroform: Methanol: Ammonia (90: 0:1), Methylene chloride: Methanol 
(1:1), 1%Ammonia or 1% Acetic acid 
-  Dry the plates and store in dust free atmosphere  
 
Activation of pre-coated plates 
- Freshly open box of plates do not require activation 
-  Plates exposed to high humidity or kept on hand for long time to be activated  By 
placing in an oven at 110-120ºc for 30’ prior to spotting,  
- Aluminum sheets should be kept in between two glass plates and placing in oven at 
110-120ºc for 15 minutes.  
 
Application of sample and standard 
-  Usual concentration range is 0.1-1µg / µl 
- Above this causes poor separation 
-  Linomat IV (automatic applicator) - nitrogen gas sprays sample and standard from 
syringe on TLC plates as bands 
-  Band wise application 
-  Better separation  
-  High response to densitometer  
 
Selection of mobile phase 
 
-  Trial and error  
- One’s own experience and Literature 
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Normal phase  
 
- Stationary phase is polar 
- Mobile phase is non polar 
-  Non-polar compounds eluted first because of lower affinity with stationary phase 
-  Polar compounds retained because of higher affinity with the stationary phase 
 
Reversed phase 
 
-  Stationary phase is non polar 
- Mobile phase is polar 
-  Polar compounds eluted first because of lower affinity with stationary phase 
-  Non-Polar compounds retained because of higher affinity with the stationary phase 
- 3-4 component mobile phase should be avoided 
-  Multi component mobile phase once used not recommended for further use and 
solvent composition is expressed by volumes (v/v) and sum of volumes is usually 100 
-  Twin trough chambers are used only 10 -15 ml of mobile phase is required 
-  Components of mobile phase should be mixed introduced into the twin trough 
chamber  
 
Pre- conditioning (Chamber saturation) 
 
-  Un- saturated chamber causes high Rf values 
-  Saturated chamber by lining with filter paper for 30 minutes prior to development  
-  Uniform distribution of solvent vapours  
-  Less solvent for the sample to travel  
-  Lower Rf values.  
 
Chromatographic development and drying 
 
-  After development, remove the plate and mobile phase is removed from the plate 
-  To avoid contamination of lab atmosphere 
-  Dry in vacuum desicator  
-  Avoid hair drier  
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-  Essential oil components may evaporate  
 
Detection and visualization 
 
- Detection under UV light is first choice  
-  Non destructive Spots of fluorescent compounds can be seen at 254 nm (short wave 
length) or at 366 nm (long wave length)  
-  Spots of non fluorescent compounds can be seen  
-  Fluorescent stationary phase is used  
-  Silica gel GF 
-  Non UV absorbing compounds like ethambutol, dicylomine etc  
-  dipping the plates in 0.1% iodine solution 
-  When individual component does not respond to UV  
-  derivatisation required for detection  
 
Quantification 
 
-  Sample and standard should be chromatographed on same plate 
-  After development chromatogram is scanned  
-  Camag TLC scanner III scan the chromatogram in reflectance or in transmittance 
mode by absorbance or by fluorescent mode  
-  Scanning speed is selectable up to 100 mm/s  
-  Spectra recording are fast - 36 tracks with up to 100 peak windows can be evaluated  
-  Calibration of single and multiple levels with linear or non-linear regressions are 
possible when target values are to be verified such as stability testing and dissolution 
profile single level calibration is suitable 
-  Statistics such as RSD or CI report automatically  
-  Concentration of analyte in the sample is calculated by considering the sample 
initially taken and dilution factors. 
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1. Retention factor (Rf)  
 
Retention factor (Rf) is defined as the amount of separation due to the solvent 
migration through the sorbent layer as shown in the formula.  It depends on time of 
development and velocity coefficient or solvent front velocity.  
 
                                                            Migration distance of substance  
                        Rf         =          --------------------------------------------------------  
                                                Migration distance of solvent front from origin  
 
 
2. Peak purity  
 
The null hypothesis “these spectra are identical” can in this case (purity) with two 
sided significance.  During the purity test the spectrum taken at the first peak slope is 
correlated with the spectrum of peak maximum [r(s,m)] and the correlation of the spectra 
taken at the peak maximum with the one from the down slope or peak end [r(m,e)] which is 
used as a reference spectra for statistical calculation.  An error probability of 1% only is 
rejected if the test value is greater than or equal to 2.576.  
 
VALIDATION OF ANALYTICAL METHOD 
    
         Validation is an act of proving that any procedure, process, equipment, material, 
activity or system performs as expected under given set of conditions and also give the 
required accuracy, precision, sensitivity, ruggedness, etc.  
 
When extended to an analytical procedure, depending upon the application, it means 
that a method works reproducibly, when carried out by same or different persons, in same or 
different laboratories, using different reagents, different equipments, etc.  
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The various validation parameters are  
 
1. Accuracy,  
2. Precision(Repeatability and Reproducibility),  
3. Linearity and range,  
4. Limit of detection (LOD)/ limit of quantization (LOQ),  
5. Selectivity/ specificity,  
6. Robustness/ ruggedness and  
7. Stability and system suitability studies.  
Advantages of Analytical method Validation 
 
The biggest advantage of method validation is that it builds a degree of confidence, 
not only for the developer but also to the user.  
 
Although the validation exercise may appear costly and time consuming, it results 
inexpensive, eliminates frustrating repetitions and leads to better time management in the 
end.  
 
Minor changes in the conditions such as reagent supplier or grade, analytical setup are 
unavoidable due to obvious reasons but the method validation absorbs the shock of such 
conditions and pays for more than invested on the process. 
 
ANALYTICAL METHOD VALIDATION  
Key Parameters of the Analytical Method Validation 
 
It is important for one to understand the parameters or characteristics involved in the 
validation process. The various Performance parameters, which are addressed in a validation 
exercise, are grouped as follows.  
 
(1)  Accuracy 
 
The accuracy of an analytical method may be defined as the closeness of the test 
results obtained by the method to the true value. It is the measure of the exactness of the 
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analytical method developed. Accuracy may often express as percent recovery by the assay of 
a known amount of analyte added.  
 
Accuracy may be determined by applying the method to samples or mixtures of 
excipients to which known amount of analyte have been added both above and below the 
normal levels expected in the samples. Accuracy is then calculated from the test results as the 
percentage of the analyte recovered by the assay. Dosage form assays commonly provide 
accuracy within 3-5% of the true value.  
 
(2)  Precision  
 
The precision of an analytical method is the degree of agreement among individual 
test results when the method is applied repeatedly to multiple samplings of homogenous 
samples. This is usually expressed as the standard deviation or the relative standard deviation 
(coefficient of variation). Precision is a measure of the degree of reproducibility or of the 
repeatability of the analytical method under normal operating circumstances.  
 
Repeatability involves analysis of replicates by the analyst using the same equipment 
and method and conducting the precision study over short period of time while 
reproducibility involves precision study at  
 
§  Different Occasions,  
§  Different Laboratories,  
§  Different Batch of Reagent,  
§  Different Analysts,  
§  Different Equipments.  
 
Determination of Repeatability  
 
Repeatability can be defined as the precision of the procedure when repeated by same 
analyst under the same operating conditions (same reagents, equipments, settings and 
laboratory) over a short interval of time.  
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It is normally expected that at least six replicates be carried out and a table showing 
each individual result provided from which the mean, standard deviation and co-efficient of 
variation should be calculated for set of n value. The RSD values are important for showing 
degree of variation expected when the analytical procedure is repeated several time in a 
standard situation. (RSD below 1% for built drugs, RSD below 2% for assays in finished 
product).  
 
Determination of reproducibility  
 
Reproducibility means the precision of the procedure when it is carried out under 
different conditions-usually in different laboratories-on separate, putatively identical samples 
taken from the same homogenous batch of material. Comparisons of results obtained by 
different analysts, by the use of different equipments, or by carrying out the analysis at 
different times can also provide valuable information.  
 
(3)  Linearity and range  
 
The linearity of an analytical method is its ability to elicit test results that are directly 
(or by a well defined mathematical transformation) proportional to the analyte concentration 
in samples within a given range. Linearity usually expressed in terms of the variance around 
the slope of regression line calculated according to an established mathematical relationship 
from test results obtained by the analysis of samples with varying concentrations of analyte.  
The linear range of detectability that obeys Beer’s law is dependent on the compound 
analyzed and the detector used. The working sample concentration and samples tested for 
accuracy should be in the linear range. The claim that the method is linear is to be justified 
with additional mention of zero intercept by processing data by linear least square regression. 
Data is processed by linear least square regression declaring the regression co-efficient and b 
of the linear equation y= ax + b together with the correlation coefficient of determination r. 
For the method to be linear the r value should be close to1.  
 
The range of an analytical method is the interval between the upper and lower levels 
of the analyte (including these levels) that have been demonstrated to be determined with 
precision, accuracy and linearity using the method as written.  
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(4)  Limit of Detection and limit of Quantification:-  
Limit of detection:-  
 
The limit of detection is the parameter of limit tests. It is the lowest level of analyte 
that can be detected, but not necessarily determined in a quantitative fashion, using a specific 
method under the required experimental conditions. The limit test thus merely substantiates 
that the analyte concentration is above or below a certain level.  
 
The determination of the limit of detection of instrumental procedures is carried out 
by determining the signal-to-noise ratio by comparing test results from the samples with 
known concentration of analyte with those of blank samples and establishing the minimum 
level at which the analyte can be reliably detected. A signal-to-noise ratio of 2:1 or 3:1 is 
generally accepted.  
 
The signal-to-noise ratio is determined by dividing the base peak by the standard 
deviation of all data points below a set threshold. Limit of detection is calculated by taking 
the concentration of the peak of interest divided by three times the signal-to-noise ratio.  
 
For spectroscopic techniques or other methods that rely upon a calibration curve for 
quantitative measurements, the IUPAC approach employs the standard deviation of the 
intercept (Sa) which may be related to LOD and the slope of the calibration curve, b, by  
 
LOD = 3 Sa / b 
 
Limit of quantification  
 
Limit of quantification is a parameter of quantitative assays for low levels of 
compounds in sample matrices such as impurities in bulk drugs and degradation products in 
finished pharmaceuticals. The limit of quantification is the lowest concentration of analyte in 
a sample that may be determined with acceptable accuracy and precision when the required 
procedure is applied.  
 
It is measured by analyzing samples containing known quantities of the analyte and 
determining the lowest level at which acceptable degrees of accuracy and precision are 
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attainable where the final assessment is based on an instrumental reading, the magnitude of 
background response by analyzing a number of blank samples and calculating the standard 
deviation of this response. The standard deviation multiplied by a factor (usually 10) provides 
an estimate of the limit of quantification. In many cases, the limit of quantification is 
approximately twice the limit of detection.  
 
(5)  Selectivity and Specificity  
 
The selectivity of an analytical method is its ability to measure accurately and 
specifically the analyte of interest in the presence of components that may be expected to be 
present in the sample matrix.  
 
If an analytical procedure is able to separate and resolve the various components of a 
mixture and detect the analyte qualitatively the method is called selective. On the other hand, 
if the method determines or measures quantitatively the component of interest in the sample 
matrix without separation, it is said to be specific.  
Hence one basic difference in the selectivity and specificity is that, while the former is 
restricted to qualitative detection of the components of a sample, the latter means quantitative 
measurement of one or more analyte.  
 
Selectivity may be expressed in terms of the bias of the assay results obtained when 
the procedure is applied to the analyte in the presence of expected levels of other 
components, compared the results obtained when the procedure is applied to the analyte in 
the presence of expected levels of other components, compared to the results obtained on the 
same analyte without added substances. When the other components are all known and 
available, selectivity may be determined by comparing the test results obtained on the analyte 
with and without the addition of the potentially interfering materials. When such components 
are either unidentified or unavailable, a measure of selectivity can often be obtained by 
determining the recovery of a standard addition of pure analyte to a material containing a 
constant level of the other components.  
 
(6) Robustness and Ruggedness  
Robustness  
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The robustness of an analytical method is a measure of its capacity to remain 
unaffected by small but deliberate variation in method parameters and provides an indication 
of its reliability during normal usage. The determination of robustness requires that methods 
characteristic are assessed when one or more operating parameter varied.  
  
           Ruggedness  
 
The ruggedness of an analytical method is the degree of reproducibility of test results 
obtained by the analysis of the same samples under a variety of normal test  conditions such 
as different laboratories, different analysts, using operational and environmental conditions 
that may differ but are still within the specified parameters of the assay. The testing of 
ruggedness is normally suggested when the method is to be used in more than one laboratory. 
Ruggedness is normally expressed as the lack of the influence on the test results of 
operational and environmental variables of the analytical method.  
 
For the determination of ruggedness, the degree of reproducibility of test result is 
determined as function of the assay variable. This reproducibility may be compared to the 
precision of the assay under normal condition to obtain a measure of the ruggedness of the 
analytical method.  
 
(7)  Stability and System suitability tests  
 
Stability of the sample, standard and reagents is required for a reasonable time to 
generate reproducible and reliable results. For example, 24 hour stability is desired for 
solutions and reagents that need to be prepared for each analysis.  
 
System suitability test provide the added assurance that on a specific occasion the 
method is giving, accurate and precise results. System suitability test are run every time a 
method is used either before or during analysis. The results of each system suitability test are 
compared with defined acceptance criteria and if they pass, the method is deemed satisfactory 
on that occasion. The nature of the test and the acceptance criteria will be based upon data 
generated during method development optimization and validation experiments.  
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Data Elements Required For Assay Validation  
 
There are various analytical methods used for the examination of pharmaceutical 
materials. Not all the characteristics referred above will need to be considered in all cases. 
Analytical methods may be broadly classified as Per WHO as follows:  
Class A  Tests designed to establish identity, whether of bulk drug substances or of a 
particular ingredient in a finished dosage form.  
Class B  Methods designed to detect and quantitative impurities in a bulk drug 
substance or finished dosage form.  
Class C  Methods used to determine quantitatively the concentration of a bulk drug 
substance or of a major ingredient in a finished dosage form.  
Class D  Methods used to assess the characteristic of finished dosage forms, such as 
dissolution profiles and content uniformity.  
 
Table: Characteristic that should be considered for different types of analytical 
procedure:  
 Class A 
Class B 
Class C Class D Quantitative 
tests 
Limit tests 
Accuracy  X  X X 
Precision  X  X X 
Robustness X X X X X 
Linearity and 
range 
 X  X X 
Selectivity X X X X X 
Limit of 
Detection 
X  X   
Limit of 
Quantification 
 X    
 
Where, X indicates the tests to be performed.  
Introduction of Analytical Chemistry   
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences Page 21 
 
As per USP 
 
Category I   
 
Analytical methods for quantification of major components of bulk drug substances or 
active ingredients including preservatives in finished pharmaceutical products.  
 
Category II  
 
Analytical methods for determination of impurities in bulk drugs or for determination 
of degradation compounds in finished pharmaceutical products. 
 
Category III  
 
Analytical methods for determination of performance characteristics (e.g. dissolution, 
drug release). 
 
Category IV  
Identification tests.  
 
Table: Data Elements Required for Assay Validation 
Analytical 
Performance 
Characteristics 
Assay 
Category 
I 
Assay Category II S Assay 
Category 
IV 
Quantitative 
tests 
Limit 
tests 
Accuracy X X May be May be  
Precision X X  X  
Specificity X X X May be X 
Limit of Detection   X May be  
Limit of 
Quantification 
 X  May be  
Linearity X X  May be  
Range X X May be May be  
Where, X indicates the tests to be performed.  
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Conclusion 
 
The efficient development and validation of analytical methods are critical elements 
in the development of pharmaceuticals. Success in these areas can be attributed to several 
important factors, which in turn will contribute to regulatory compliance. Experience is one 
of these factors both the experience level of the individual scientists and the collective 
experience level of the development and validation department. 
                                                                                          Review of Literature 
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences Page 23 
 
REVIEW OF LITERATURES 
1. LIST OF ANALYTICAL METHOD AVAILABLE FOR ONDANSETRON 
HYDROCHLORIDE 
 Mehta kalpesh K7, et al., reported Spectrophotometric methods for formulation and 
process optimization of Gastro Retentive floating tablets of ondansetron 
HCL.Absorbance of each solution was measured at 310 nm using Shimadzu UV-VIS 
double beam spectrophotometer. 
 
 S Pillai23,et al., reported Spectrophotometric simultaneous estimation of ranitidine 
hydrochloride and ondansetron hydrochloride from tablet formulation. First 
developed method involves formation and solving of simultaneous equations at 267.2 
nm and 314.4 nm. Second method was developed making use of first order derivative 
spectroscopy using 340.8 nm and 276.0 nm as zero crossing points for estimation of 
ranitidine hydrochloride and ondansetron hydrochloride respectively. Third method is 
based on two wavelength calculation, wavelengths selected for estimation of 
ranitidine hydrochloride were 266.1 nm and 301.8 nm and for ondansetron 
hydrochloride 305.7 nm and 319.2 nm.  
 
 
 Sradhanjali Patra13,et al., reported Spectrophotometric method for ondansetron 
hydrochloride. It shows maximum absorbance at 310 nm with water.  
 
 Steffen Bauer24,et al., reported Simultaneous determination of ondansetron and 
tropisetron in human plasma using HPLC with UV detection. The lower limits of 
quantification (LOQ) were 0.62 ng/mL for ondansetron and 1.25 ng/mL or 
tropisetron. Intra- and inter-assay coefficients of variation ranged from 1.5 to 7.5% 
and 5.3 to 13.7%, respectively.  
 
 
 Jawed Akhtar25, et al., reported Spectrophotometric Methods for Simultaneous 
Estimation of Rabeprazole Sodium and Ondansetron. For simultaneous equation 
method RAB shows maximum absorbance at 284.20 nm and OND shows at 246.0 
nm. 
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 P Yeole8, .et al., reported A Validated HPTLC Method for Determination of 
Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form. 
The method involved separation of components by TLC on a precoated silica gel 60 F 
254 using a mixture of dichloromethane:methanol (9:1) as a mobile phase. Detection 
of spots was carried out at 309 nm and 294 nm . 
 
 Raval P B26., et al., reported A validated HPTLC method for determination of 
ondansetron in combination with omeprazole or rabeprazole in solid dosage form. The 
method involved separation of components by TLC on a precoated silica gel 60 
F(254) using a mixture of dichloromethane:methanol (9:1) as a mobile phase. 
Detection of spots was carried out at 309 nm and 294 nm. 
 
 
 P. Ravi Kumar9., et al., reported Derivative Spectrophotometric Estimation of 
Ondansetron and Paracetamol. Ondansetron and paracetamol have λmax at 302 nm 
and 246 nm respectively in methanol.  
 
 Lobhe GA27., et al., reported Simultaneous Spectrophotometric methods for 
estimation of Ondansetron Hydrochloride and Omeprazole in tablets. In ethanol, 
ondansetron hydrochloride and Omeprazole showed λmax at 246.2 nm and 301 
nm,respectively. 
 
 
 Ali Mujtaba12 et al., reported  Development of HPTLC method for the estimation of 
ondansetron hydrochloride in bulk drug and sublingual tablets. The mobile phase 
composition was chloroform: ethyl acetate: methanol: ammonia (9:5:4:0.1 v/v). 
Spectrodensitometric analysis of ondansetron was carried out at 254 nm. 
 
 Patra13, et al., reported Spectrophotometric method for ondansetron hydrochloride. It 
shows maximum absorbance at 310 nm with water. Beer's law obeys in the 
concentration range of 5-15 [micro]g/ml 
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 Bauer S14., et al., reported Simultaneous determination of ondansetron and tropisetron 
in human plasma using HPLC with UV detection. The lower limits of quantification 
(LOQ) were 0.62 ng/mL for ondansetron and 1.25 ng/mL or tropisetron. Intra- and 
inter-assay coefficients of variation ranged from 1.5 to 7.5% and 5.3 to 13.7%, 
respectively. 
 
 Srikant Nayak27.,et al., reported UV-Spectrophotometric method for simultaneous 
estimation of Paracetamol and Ondansetron in Bulk and their formulation. 267 nm for 
Ondansetron  and 248 nm for Paracetamol.solution –Methanol: double distilled water 
(9:1). Concentration range 2-20µg/ml for Paracetamol and 0.1-1µg/ml for 
Ondansetron.Recovery: 99.36% for Paracetamol and 99.99% for Ondansetron . 
 
2. LIST OF ANALYTICAL METHOD AVAILABLE FOR PROMETHAZINE 
HYDROCHLORIDE 
 
 Muhammad Jawwad Saif11 .,et al., reported A new spectrophotometric method for 
the determination of promethazine–HCl from pure and pharmaceutical 
preparation.absorbance at 515 nm. 
 
3. LIST OF ANALYTICAL METHOD AVAILABLE FOR PARACETAMOL 
 
 M Gandhimathi28. Et al., reported High performance thin layer chromatographic 
method for Simultaneous estimation of Paracetamol and Valdecoxib in tablet dosage 
from india. Chloroform:Isopropyl alcohol:Glacial acetic acid (9.5:1:0.2 v/v/v) as 
mobile phase.  
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 Caitlin Sullivan and Joseph Sherma29., reported Development and Validation of an 
HPTLC-Densitometry method for Assay of Caffeine and Acetaminophen in Multi 
component Extra Strength Analgesic Tablets.  
 
 
 Thenmozhi15., et al., reported HPTLC Method For Simultaneous Estimation Of 
Tramadol Hydrochloride And Paracetamol In Combined Tablet Dosage. In this 
method pre coated silica gel 60 GF 254 TLC plate was used as stationary phase and 
the chromatogram was developed using Toluene: Ethylacetae: Methanol: Glacial 
acetic acid (40:30:28:2 % v/v/v/v) as mobile phase. The plate was scanned and 
quantified at 276 nm using Camag TLC Scanner. 
 
 Khatal LD., et al., reported Validated HPTLC method for simultaneous quantitation 
of paracetamol, diclofenac potassium, and famotidine in tablet formulation. The 
method used HPTLC aluminum plates precoated with silica gel 60F254 as the 
stationary phase, and the mobile phase consisted of toluene-acetone-methanol-formic 
acid (5 + 2 + 2 + 0.01, v/v/v/v). Densitometric evaluation of the separated zones was 
performed at 274 nm.  
 
 C. Roosewelt17 .,et., reported Simultaneous Estimation and Validation of Tramadol 
and Paracetamol by HPTLC in Pure and Pharmaceutical Dosage Form. It was 
performed on TLC plate pre-coated with silica get 60F254 as a stationary phase using 
mobile phase comprising of chloroform:methanol:glacial acetic acid (90:20:1) and the 
detection was carried out of 270 nm. 
 Santosh V18., et al., reported Simultaneous HPTLC determination of nabumetone and 
paracetamol in combined tablet dosage form. The separations were carried out on 
Merck aluminum plates precoated with silica gel 60 F254, using toluene:2-
propanol:acetic acid (8:2:0.1, v/v/v) as mobile phase. Quantitative determination of 
bands was done by densitometric scanning at 236 nm. 
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 Kanchan Raut19., et al ., reported Validated HPTLC Method for Simultaneous 
Estimation of Paracetamol and Etoricoxib in Bulk Drug and Formulation. 
Chromatographic separation of the drugs were performed on aluminum plates 
precoated with silica gel 60 F254 as the stationary phase and the solvent system 
consisted of toluene: ethyl acetate: methanol in the ratio of 6: 4: 1 
(v/v/v).Densitometric evaluation of the separated zones was performed at 263 nm. 
 
 
 K. G. Baheti20 ., et al., reported  Validated Simultaneous Estimation of Paracetamol 
and Etoricoxib in Bulk and Tablet by HPTLC Method. A good linear relationship 
with regression coefficient 0.998 and 0.995 in the concentration range of 100-600 
ng/spot and 200-1200 ng/spot for paracetamol and etoricoxib respectively was 
obtained. The recovery study was carried out by standard method and results were in 
the range of 98 to 102 %.  
 
 Janhavi R21 ., et al., reported Simultaneous HPTLC Determination of Paracetamol 
and Dexketoprofen trometamol in pharmaceutical dosage form. Silica gel G 60F254 
plates were used as stationary phase and toluene: ethyl acetate: acetic acid (6: 4: 0.2 
v/v/v) as mobile phase. Wavelength selected for analysis was 256 nm.  
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DRUG PROFILE3-4 
 
ONDANSETRON HYDROCHLORIDE  
Official in Indian Pharmacopeia 
Chemical Name 
Chemically acebrophylline is 1, 2, 3, 6-tetrahydro-1, 3-dimethyl-2, 6-dioxo-7H purine-7-
acetic acid with trans- 4-[(2-amino-3, 5-dibromophenyl) methyl] amino] cyclohexanol. 
Structure  
 
Molecular formula  
 C18H19 N3 O.HCl.2 H2O 
Molecular weight  
365.86 
Description  
White to off white colour 
Solubility  
Very soluble in acid soloution.Sparingly soluble in water 
Mode of Action  
Ondansetron is a potent, highly selective  5 HT3 receptor –antagonist. Its precise mode of 
action in the control of  nausea and vomiting is not known. Chemotherapeutic agents and 
radiotherapy  may cause release of  5HT in the small intestine initiating  a vomiting reflux by 
                                                                                                                Drug Profile 
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences Page 29 
 
activating  vagal afferents  via 5 HT3 receptors. Ondansetron blocks  the initiation of this 
reflex. Activation of vagal afferents  may also cause a release of 5 HT in the area postrema  
located on the floor  of the fourth ventricle ,and this may also  promote emesis through a 
central mechanism. Thus , the effect  of ondansetron  in the management of  the  nausea and 
vomiting  induced by cytotoxic  chemotherapy  and radiotheraphy  is due to  antagonism of 
5HT3 receptors on neurones  located both in the  peripheral  and central nervous system. The 
mechanisms of action in post-operative nausea and vomiting  are not known but there may be 
common pathways  with cytotoxic induced nausea and vomiting .In  psychomotor testing 
ondansetron does not impair performance nor cause sedation. Ondansetron does not alter 
plasma prolactin concentrations. 
A study in cloned human cardiac ion channels  has shown ondansetron has the potential to 
affect cardiac repolarisation  via blockade of HERG potassium channels. The clinical 
relevance of this finding is uncertain. 
Therapeutic Category  
Prevention and treatment of nausea and vomiting 
Pharmacological Action  
Ondansetron is a selective 5-HT3 receptor –antagonist.Chemotherapeutic agents and 
radiotherapy may cause release of 5-HT in the small intestine initiating a vomiting reflex by 
activating vagal afferents via 5-HT3 receptors. The initiation of this reflex is blocked by 
ondansetron. Activation of vagal afferents may also cause a release of 5HT in the area 
postrema,located on the floor of the fourth ventricle,and this may also promote emesis 
through a central mechanism. Thus the effect of ondansetron  in the management of  the 
nausea and vomiting induced by chemotheraphy and radiotheraphy may be due to the 
antagonism of 5-HT3 receptors on neurons located both in the peripheral and central nervous 
system. 
In psychomotor testing,ondansetron does not cause sedation nor impair performance. 
Dose  
4 mg 3 times a day 
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DRUG PROFILE4-5 
 
PROMETHAZINE HYDROCHLORIDE 
Official in Indian Pharmacopeia.  
Chemical Name 
Dimethyl [ 1-(10H-phenothiazin-10-yl)propan-2-yl]amine 
Structure  
 
 
Molecular Formula  
C17H20 N2 S 
Molecular Weight  
 419.45 g / mol 
Description 
White to faint yellow crystalline powder that is practically odorless. 
 
Solubility  
It is very soluble in water, freely soluble in alcohol and in chloroform and practically 
insoluble in ether.               
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Mode of Action  
Competitively blockts H1 receptors. Possesses sedative ,antemetic and anticholinergic 
properties. The relief of motion sickness and nausea/vomiting  appear  to be related to central 
anticholinergic actions and may implicate activity on the medularry chemoreceptor trigger 
zone. 
Therapeutic Category   
Antiemetic and anticholinergic 
Pharmacological Action  
Promethazine  is a phenothazine derivative which differs structurally from the antipsychotic 
phenothazines by the presence of a branched side chain and no ring substitution. It is  thought 
that this configuration is responsible for its relative lack (1/10 that of chlorpromazine) of 
dopamine antagonist properties.                                         
Promethazine is an H1 receptor blocking agent. In addition to its antihistamininc action,it 
provides clinically useful sedative and antiemetic effects. 
Promethazine is well absorbed from the gastrointestinal tract. Clinical effects are apparent 
within 20 minutes after oral administration and generally last four to six hours,although they 
may persist as long as 12 hours. Promethazine is metabolized the liver to a variety of 
compounds; the sulfaoxides of promethazine and N-desmethyl promethazine are the 
predominant metabolites appearing in the urine. 
 Dose 
The recommended dose of promethazine for treating allergies in most people is 25 mg before 
bedtime. For the treatment of nausea and vomiting, guidelines call for 12.5 to 25 mg, taken 
every four to six hours as needed. The standard recommended amount for treating morning 
sickness is 25 mg twice daily. Dosing for children is determined by the child's weight. 
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DRUG PROFILE6 
 
PARACETAMOL 
Official in Indian Pharmacopeia.  
 
Chemical Name 
Chemically it is N-(4-hydroxyphenyl)acetanilide. 
Structure  
 
 
 
Molecular Formula  
C8H9 NO2  
 Molecular Weight  
151.16 g / mol 
 
Description 
A White solid crystalline powder. 
Solubility  
Slightly Soluble in water, soluble in organic solvents such as methanol,ethanol,insoluble in 
petroleum ether,benzene. 
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Mode of Action  
The mechanism by which Paracetamol reduces fever and pain is still a source of  
debate. The reason for this confusion has largely been due to the fact that paracetamol 
reduces the production of prostaglandins.  
Therapeutic Category   
Paracetamol is non steroid anti inflammatory drug 
 
Pharmacological Action  
Acetaminophen is thought to act primarily in the CNS increasing the pain threshold by 
inhibiting both is forms of cyclooxygenase; COX-1, COX-2 and COX-3 enzymes involved in 
prostaglandin (PG) synthesis. Unlike NSAIDs, acetaminophen does not inhibit 
cyclooxygenase in peripheral tissues and, thus, has no peripheral anti-inflammatory affects. 
While aspirin acts as an irreversible inhibitor of COX and directly blocks the enzyme’s active 
site,studies have found that acetaminophen indirectly blocks COX, and that this blockade is 
in effective in the presence of peroxides. This might explain why acetaminophen is effective 
in the central nervous system and in endothelial cells but not in platelets and immune cells 
which have high levels of peroxides. Studies also report data suggesting that acetaminophen 
selectively blocks a poorly understood, but future research may provide further insight into 
how it works. The antipyretic properties of acetaminophen are likely due to direct effects on 
the heat-regulating centres of the hypothalamus resulting in peripheral vasodilation,sweating 
and hence heat dissipation. 
Dose 
0.5 to 1 gm 4 to 6 hours as necessary  
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                                                      AIM AND OBJECTIVE 
 Literature survey revealed that various analytical methods like UV-
Spectrophotometry,HPLC and HPTLC methods, have been reported for the estimation of 
Ondansetron Hcl, Promethazine Hcl and  Paracetamol, individually and combination with 
some other drugs. No methods for estimation of Ondansetron Hcl with Promethazine by 
using UV-Spectroscopy and Ondansetron Hcl with Paracetamol by using HPTLC. 
The review of literature prompted us to develop a new validated UV Spectroscopic 
method for the estimation of Ondansetron Hcl with Promethazine Hcl and a HPTLC method 
for  Ondansetron with Paracetamol in pharmaceutical dosage forms. 
Aim: 
1. To develop a UV-Spectroscopic method for the Simultaneous estimation of 
Ondansetron Hcl with Promethazine Hcl in formulation. 
2. To develop and validate a HPTLC method for Simultaneous estimation of 
Ondansetron Hcl and Paracetamol in formulation. 
Objective: 
1. To procure pure samples from Bulk drug  industry 
2. To find the linearity range of the drugs to be estimated with suitable solvents & 
mobile phase using UV and HPTLC. 
3. To prepare the formulation dilution inside the linearity range to evaluate the drug 
content. 
4. To validate the developed method according to FDA, USP & ICH guidelines. 
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LIST OF INSTRUMENTS USED 
 
S. No. Instruments 
1.  Elico SL-164 UV-VIS Spectrophotometer 
2.  Camag HPTLC Instrument 
3.  Camag TLC Scanner 3 
4.  Camag Linnomate V Automatic Sample Applicator 
5.  Twin-trough chamber (10×10 cm) 
6.  Hamilton syringe (20 μl) 
7.  Electronic Balance 
8.  Ultra sonicator 
9.  pH Analyzer 
10.  Camag–Reprostar –3 instrument 
 
 
 
 
 
  
                                                                                  Materials And Instrument 
 
Department Of Pharmaceutical Analysis, RVS College Of Pharmaceutical Sciences Page 36 
 
 
 
LIST OF CHEMICALS AND SOLVENTS 
 
S. No Chemicals and Solvents 
1.   Ondansetron Hydrochloride working standard 
2. Promethazine Hydrochloride working standard 
3. Paracetamol  working standard 
4. Chloroform (AR Grade) 
 
5. 
 
Distilled water (AR Grade) 
6. Dichloromethane (AR Grade) 
 
7. 
 
Methanol (AR Grade) 
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SIMULTANEOUS ESTIMATION OF ONDANSETRON HYDROCHLORIDE AND 
PROMETHAZINE HYDROCHLORIDE BY UV – SPECTROSCOPY IN BULK AND 
PHARMACETICAL DOSAGE FORM 
 
Study of spectra and selection of wave length  
The aliquot portion of standard stock solution of Ondansetron Hcl and Promethazine Hcl 
were diluted appropriately with Chloroform to obtain 10 µg/ml each respectively and the 
solutions were scanned in the range of 200-400 nm in 1.0 cm cell against chloroform as blank 
and the λ max for Ondansetron Hcl and Promethazine Hcl was found to be 310 nm and 250 
nm respectively. 
 Standard Solution 
a) Ondansetron Hydrochloride standard stock solution  
An accurately weighed quantity of Ondansetron Hcl equivalent to 100mg was dissolved in 
chloroform and volume was made up to 100ml with same solvent to produce 1000µg/ml. 
b) Promethazine Hydrochloride standard stock solution 
An accurately weighed quantity of Promethazine Hcl equivalent to 100mg was dissolved in 
Chloroform and volume was made up to 100ml with same solvent to produce 1000µg/ml. 
Study of Beer Lambert’s law  
 The aliquots   portion   of standard stock solutions of Ondansetron Hcl and Promethazine Hcl 
were diluted to 5-25 µg/ml and 10-50 µg/ml respectively and absorbance was measured at 
310 nm and 250 nm. (Fig.1-10)  
Determination of Absorptive value and Concentration in Pure Drug 
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By Simultaneous Equation Method (or) Vierodt’s Method 
The absorbance at the 310 nm and 250 nm for Ondansetron Hcl and Promethazine  Hcl 
respectively were measured and calibration curves were plotted. The absorptive values for the 
drugs are then calculated by ax1, ax2, ay1 and ay2. The absorbance of the sample mixture was 
measured at λ1 and λ2 and recorded as A1 and A2 by following equation. The absorbance 
graphs of pure drug samples of Ondansetron Hcl and Promethazine Hcl were given. (Fig.1-
10) 
 
                             Cx = A1ax2-A2ax1/ax2ay1-ax1ay2   ------------- 1 
                             Cy = A2ax1-A1ax2/ax2ay1-ax1ay2    ------------- 2 
 
Where, 
 
   ax1 = the absorptivity valve of Ondansetron at 310.0 nm.  
   ax2 = the absorptivity valve of Ondansetron at 250.0 nm. 
   ay1 = the absorptivity valve of Promethazine at 310.0 nm. 
   ay2 = the absorptivity valve of Promethazine at 250.0 nm. 
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Fig.1. Ondansetron Hcl 5 µg/ml at 310 nm 
 
 
Fig. 2 Ondansetron Hcl 10 µg/ml at 310 nm 
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Fig.3 Ondansetron Hcl 15 µg/ml at 310 nm 
 
   
 
Fig.4 Ondansetron  Hcl 20 µg/ml at 310 nm 
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Fig.5 Ondansetron Hcl 25 µg/ml at 310 nm 
Fig.6 Promethazine Hcl 10 µg/ml at 250 nm 
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Fig.7 Promethazine Hcl 20µg/ml at 250 nm 
 
Fig.8 Promethazine Hcl 30 µg/ml at 250 nm 
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Fig.9 Promethazine Hcl 40 µg/ml at 250 nm 
 
Fig.10 Promethazine Hcl 50 µg/ml at 250 nm 
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Analysis of Formulation 
 
 Twenty tablets are weighed and powdered. A quantity equivalent to 4 mg of 
Ondansetron and 25 mg of Promethazine was taken in 100 ml volumetric flask, dissolved in 
Chloroform and sonicated for 10 min. The volume was then made up to the mark using same 
solvent. The resulting solution was filtered through Whatmann filter paper grade I and from 
filtrate 1ml was taken and the volume was made up to 100 ml to get the approximate 
concentration of 20 μg/ml of Ondansetron . Absorbances of 10 µg/ml sample solution were 
recorded at 310.0 nm and 250.0 nm and the concentration of two drugs in the sample were 
determined by using simultaneous equation. The results are shown in Fig.11 and table. 
 
Fig.11 Ondansetron Hcl 10 µg/ml in Formulation (Vomicare P) 
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Table.1 Analysis of Formulation 
Formulation Label claim Amount found   
% RSD* 
% Assay 
RSD* 
Vomicare-P 
tablets 
Ondansetron Hcl 4 mg 3.95 98.75 
Promethazine Hcl 25 mg  24.92 99.68 
 
* RSD for Three Determinations 
Method Validation 
The developed method was validated in terms of accuracy, precision and stability. The 
validation parameters are shown in table.2 
Table.2 Validation Parameters 
Parameters Ondansetron  Hcl 310 
nm 
Promethazine  Hcl     
250nm 
Linearity Range(μg/ml) 5-25 10-50 
Coefficient of Correlation 0.998 0.999 
Slope 0.038 0.018 
Intercept 0.011 
 
          0.009 
 
Repeatability (% RSD) 
Intraday precision 
Interday precision 
0.39-1.47 
0.13-1.38 
0.22-0.96 
0.23-77 
0.29-1.08 
0.25-1.38 
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Linearity and Range  
 
The aliquot portion of stock standard solutions of Ondansetron Hcl and Promethazin Hcl 
were diluted with Chloroform to get the series of concentration 5-25µg/ml and 10-50 µg/ml 
respectively. To construct Beer’s law plot for Ondansetron Hcl and Promethazine Hcl, a 
standard graph was plotted by taking concentration of drug on x-axis and absorbance on y-
axis and was shown in Fig.12 and 13. The drug has obeyed Beer’s law. The regression 
coefficient for Ondansetron Hcl and Promethazine Hcl was found to be 0.998 at 310 nm and 
0.999 at 250 nm. The results were shown in table.3 and Fig 12 and 13. 
 
 
Table.3 Linearity and Range 
  
SL. 
No 
Concentration μg/ml Absorbance at 
 
Ondansetron Hcl 
Promethazine 
Hcl 
Ondansetron Hcl
310 nm 
Promethazine Hcl 
 250 nm  
1 5 10 0.210 0.192 
2 10 20 0.411 0.380 
3 15 30 0.567 0.568 
4 20 40 0.790 0.730 
5 25 50 0.960 0.900 
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Fig.12 Calibration curve of Ondansetron Hcl 
 
 
 
 
 
Fig.13 Calibration curve of Promethazine Hcl 
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Accuracy 
        To study the accuracy and reproducibility of the proposed methods, recovery studies 
were carried out by adding known amount of drugs to pre-analyzed sample at three levels and 
the percentage recovery was calculated. The results are summarized in table.4 
The % recovery was calculated by using the following formula 
 
%Recovery     =      Amount of drug                          Amount of drug 
                                found after addition         -         found in sample before 
                                of standard drug                          addition of standard drug     ×   100 
                                                  Amount of standard drug added                                                                          
 
Table.4 Recovery Studies 
Recovery 
Level 
Amt. of drug 
added (mg) 
Amt. of drug found 
(mg) 
Mean %  Recovery * 
+%RSD 
Ond 
Hcl 
Pro 
Hcl 
Ond Hcl  Pro Hcl Ond 
Hcl 
Pro 
Hcl 
Ond Hcl Pro Hcl 
Level 
1 
80%      3.2 20 3.18 20.21 3.2 20.08 100.0%+0.05 
 
100.40%+0.11 
3.19 20.07 
3.23 19.98 
Level 
2 
100% 4 25 4.04 24.90 4.01 25.03 100.25%+0.03 
 
100.12%+0.17 
4.01 25.23 
3.98 24.97 
Level 
3 
120% 4.8 30 4.81 29.97 4.80 30.03 100.1%+0.005 
 
99.91%+0.07 
4.80 30.02 
4.81 30.11 
  
* RSD for three Determinations 
 
Ond = Ondansetron, Pro = Promethazine 
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Precision 
Precision and accuracy together determine the error of an individual determination. They are 
among the most important criteria for judging analytical procedures by their results.  
Precision refers to the reproducibility of measurement within a set, that is, to the scatter of 
dispersion of a set about its central value. The term ‘set’ is defined as referring to a number 
(n) of independent replicate measurements of some property. One of the most common 
statistical terms employed is the standard deviation of a population of observation. Standard 
deviation is the square root of the sum of squares of deviations of individual results for the 
mean, divided by one less than the number of results in the set. The standard deviation S, is 
given by 
 
S =  
 
Standard deviation has the same units as the property being measured. 
The square of standard deviation is called variance (S2). Relative standard deviation is the 
standard deviation expressed as a fraction of the mean, i.e., S/x. It is some times multiplied 
by 100 and expressed as a percent relative standard deviation. It becomes a more reliable 
expression of precision.  
% Relative standard deviation = S x 100 / x 
       
 
 
 
 
( )∑
−
−−
n
1i
2
i xx1n
1
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Table 5. Repeatability   studies for Ondansetron Hcl 
Concentration in µg/ml Absorbance               %RSD 
 
 
 
1 
0.210  
 
 
1.47 
0.218 
0.219 
0.217 
0.217 
0.216 
 
 
5 
0.960  
 
0.39 
0.953 
0.951 
0.950 
0.955 
0.951 
 
Table 6. Repeatability   studies for Promethazine Hcl 
Concentration in µg/ml Absorbance               %RSD 
 
 
 
1 
0.192  
 
 
0.77 
0.190 
0.191 
0.193 
0.189 
0.190 
 
 
5 
0.900  
 
0.23 
0.902 
0.899 
0.905 
0.902 
0.901 
 
Table 7: Inter-day precision for Ondansetron Hcl 
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  Concentration            
µg/ml) 
           Day Absorbance    %RSD 
 
 
 
                1 
 
 
1 0.213  
 
0.96 
2 0.215 
3 0.212 
4 0.209 
5 0.211 
6 0.213 
 
 
 
5 
 
1 0.960 0.22 
2 0.963 
3 0.958 
4 0.957 
5 0.961 
                6 0.960 
 
Table 8: Inter-day precision for Promethazine Hcl 
  Concentration            
µg/ml) 
           Day Absorbance    %RSD 
 
 
 
                1 
 
 
1 0.193  1.38 
2 0.188 
3 0.195 
4 0.194 
5 0.190 
6 0.191 
 
 
 
5 
 
1 0.902  
 
   0.25 
2 0.903 
3 0.899 
4 0.904 
5 0.900 
                6 0.905 
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Table 9. Intra-day precision for Ondansetron Hcl 
Concentration µg/ml 6 times in a day Absorbance      %RSD 
 
 
 
1 
1 0.201  
0.70 
 
2 0.200 
3 0.201 
4 0.199 
5 0.203 
6 0.202 
 
 
 
                5 
1 0.912 0.13 
2 0.913 
3 0.910 
4 0.911 
5 0.913 
6 0.913 
 
Table. 10 Intra-days precision for Promethazine Hcl 
Concentration µg/ml 6 times in a day Absorbance      %RSD 
 
 
 
1 
1 0.185  
1.14 
    
2 0.182 
3 0.181 
4 0.179 
5 0.180 
6 0.182 
 
 
 
                5 
1 0.900  0.90 
 
  
2 0.901 
3 0.901 
4 0.902 
5 0.905 
6 0.907 
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Stability   
The stability studies of the drugs solution were carried out. The drugs solution was found to 
be stable at room temperature and results were shown in table.11 
Table.11 Stability Study 
 
 
 
 
Drug Concentration (µg/ml) 
Time(min.) 
Absorbance’s 
OND Hcl PRO Hcl OND Hcl PRO Hcl 
10µg/ml 10µg/ml 
30 0.411 0.192 
60 0.416 0.198 
90 0.418 0.193 
120 0.411 0.190 
150 0.414 0.191 
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SIMULTANEOUS ESTIMATION OF ONDANSETRON HCL AND PARACETAMOL 
BY HPTLC IN BULK AND PHARMACETICAL DOSAGE FORM  
METHOD DEVELOPMENT: 
1. Selection of Mobile Phase: 
 The selection of mobile phase was done by trial and error method in which several 
mobile phases were tried. The best mobile phase was selected based on the Rf value of the 
drugs. The mobile phase tried were listed below, 
1. Chloroform :Isopropyl alcohol : Glacial acetic acid (8:1:1) 
2. Chloroform: Methanol:Glacial acetic acid  (8:1:1) 
3. Dichloromethane: Methanol: Glacial acetic acid (8:1:1:) 
4. Dichloromethane:Methanol (9:1) 
2. Fixed Mobile Phase:  
 For Ondansetron and Paracetamol Dichloromethane:Methanol (9:1% v/v/) was 
selected as mobile Phase. 
3. Activation of Pre-Coated Plates: 
 Activated by placing in oven at110-120ºc for 30 minutes after sample spotting 
4. Sample Preparation: 
PROCEDURE 
The given Formulation Mixture (Ondansetron Hcl-Paracetamol 1 : 125 Ratio) was weighed in 
an Electronic balance (Afcoset) and dissolved in 90 : 10 Methanol-water centrifuged and the 
supernatant liquid was taken for the HPTLC studies.  This solution contains 4µg of 
Ondansetron and 500µg of Paracetamol drug sample in 20µl Methanol-water 90 : 10 used as 
test solution for quantitative analysis of Ondansetron Hcl  and Paracetamol from Formulation 
Mixture. 
Standard ONDANSETRON preparation 
The given standard Ondansetron 100µg was dissolved in 1000µl with Methanol-water 90 : 
10, this solution used as working standard solution (1µg/10µ or 100ng/µl) for the analysis.   
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Standard PARACETAMOL preparation 
The given standard Paracetamol 1mg was dissolved in 100µl with Methanol-water 90 : 10, 
this solution used as working standard solution (10µg/1µl) for the analysis.   
5.Sample & Standard loading 
2µl of Sample solution (Formulation Mixture 800) and a series of 1µl, 2µl, 3µl, 4µl & 5µl 
Standard of Ondansetron Hcl solution and 1µl, 2µl, 3µl, 4µl & 5µl Standard of Paracetamol 
solution were loaded as 5mm band length in the 10 x 10 Silica gel 60F254 TLC plate using 
100µl Hamilton syringe and CAMAG-LINOMAT-5 instrument. 
6.Spot development 
The Sample and standards loaded plate was kept in Twin trough chamber 10 x 10cm with 
respective mobile phase up to 15min for Chamber saturation.  After completion of chamber 
saturation, the plate was kept in mobile phase for development up to 90mm. 
7.Photo-documentation  
The developed plate was dried by hot-air to evaporate solvents from the plate and the plate 
was kept in Photo-documentation chamber.  The images of developed plate were captured at 
white light, UV 254nm and UV 366nm using CAMAG-REPROSTAR-3 instrument. 
8.Scanning 
The developed plate was scanned before derivatization in UV 254nm wavelength for 
Ondansetron Hcl compound and Paracetamol compound using CAMAG-TLC SCANNER-3 
instrument.  The Baseline display, Peak densitogram & Peak table of each track were 
obtained.  The Ondansetron Hcl and Paracetamol content present in the loaded sample was 
evaluated by Peak assignment with 5 level Ondansetron and Paracetamol standards.   
9.Spectrum scanning   
The assigned peaks of standards and sample were scanned in spectrum of UV region (200nm-
400nm) and found the λmax value of Ondansetron Hcl and Paracetamol. 
Mobile phase 
Dichloromethane-Methanol (9 : 1) 
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Detection 
Blackish brown coloured quenching zone at UV 254nm mode (Rf-0.35) before derivatization 
appeared in the given standard and sample track indicates the presence of Ondansetron Hcl 
and Dark black coloured quenching zone at UV 254nm mode (Rf 0.90) before derivatization 
showed in the given standard and sample track indicates the presence of Paracetamol. 
METHOD VALIDATION:      
 1. Linearity: 
             The linearity of both the drugs was determined by calibration curves and the linearity 
based on the area observed in the range of 10-50 µg/ml for Paracetamol and 100 –500ng/ml 
for Ondansetron Hcl.  The regression co-efficient value for Ondansetron Hcl and Paracetamol 
is       . The result shown in table 12 
Table. 12 
Parameters Ondansetron Hcl Paracetamol 
 
 
Linearity Range (µg/ml) 
100-500 ng/ml 10-50 µg/ml 
 
Concentration Peak area Concentration Peak area 
100 910.2 10 8900.2 
200 2008.7 20 17100.6 
300 3000.0 30 27283.4 
400 3844.3 40 36809.8 
500 4899.09 50 45210.9 
Coefficient Correlation 0.999 0.999 
Slope 9.781 905.9 
Y-intercept 0.80 0.35 
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Track O1- Ondansetron Hcl standard Scanning Peak densitogram display @ 254nm 
Track O2- Ondansetron Hcl standard Scanning Peak densitogram display @ 254nm 
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Track O3 – Ondansetron Hcl standard Scanning Peak densitogram display @ 254nm 
 
Track O4 – Ondansetron Hcl standard Scanning Peak densitogram display @ 254nm 
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Track O5 – Ondansetron Hcl standard Scanning Peak densitogram display @ 254nm 
 
 
Track P1- Paracetamol standard Scanning Peak densitogram display @ 254nm 
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Track P2 – Paracetamol standard Scanning Peak densitogram display @ 254nm 
 
 
 
Track P3 – Paracetamol standard Scanning Peak densitogram display @ 254nm 
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Track P4 – Paracetamol standard Scanning Peak densitogram display @ 254nm 
 
 
Track P5 - Paracetamol standard Scanning Peak densitogram display @ 254nm 
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Fig 14 Calibration Curve of Ondansetron Hcl 
                                                                                  
 
 
 
Fig.15 Calibration Curve of Paracetamol 
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2. Accuracy:  
              Accuracy of the developed method was confirmed by doing a recovery study as per 
ICH guidelines at three different concentration levels (80%, 100% and 120%) by replicate 
analysis (n=3). Standard drug solutions were added to a preanalyzed sample solution, and 
then percentage of drug content was calculated. The results of the accuracy study are reported 
in Table 16. From the recovery study, it was clear that the method is very accurate for 
quantitative estimation of Ondansetron Hcl and Paracetamol in tablet dosage form because all 
the statistical results were within the acceptance range (i.e., % RSD <2.0). 
  Table. 13                                                                   
 Recovery 
Level 
Amt. of drug 
added (mg) 
Amt. of drug found 
(mg) 
Mean %  Recovery * 
+%RSD 
Ond 
Hcl 
Para Ond Hcl       Para Ond 
Hcl 
Para Ond Hcl Para 
Level 
1 
80%      3.2 400 3.19 400.90  
3.17 
 
400.63 
99.06%+0.05 
 
100.15%+0.56 
3.11 399.98 
3.22 401.01 
Level 
2 
100% 4 500 3.95 498.89  
4.00 
 
498.65 
 
100.0%+0.07 
 
99.72%+0.59 
3.98 499.09 
4.09 497.98 
Level 
3 
120% 4.8 600 4.77 598.67  
4.79 
 
 
599.48 
 
99.79%+0.02 
 
99.91%+0.71 
4.81 600.011 
4.80 599.76 
 
* RSD for three Determinations 
 
3. Precision: 
        The precision of the method (system reproducibility) was assessed by spotting 3µl of 
drug solution six times on a TLC plate, followed by development of plate and recording the 
peak area for 6 spots. The % RSD for peak area values of Ondansetron Hcl and  Paracetamol 
found to be 0.27% & 0.11%. The results were shown in Table-17.  
             The method reproducibility (intra-day precision) was determined by analyzing 
standard solution in the concentration range of 1 µg/spot to 5 µg/spot of drug for 3 times on 
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the same day and inter-day precision was determined by analysing corresponding standards 
daily for 3 day over a period of one week.  
The intra-day and inter-day coefficients of variation (%RSD) are in range of 0.09 to 0.18, 
0.006to 0.20 and 0.03 to 0.03, 0.003 to 0.02, respectively. The results were shown in Table- 
14, 15, 16,17,18,19. 
Table – 14. Repeatability studies for Ondansetron Hcl 
Sl.No Concentration (ng/ spot) Peak Area 
1. 300     3000.0 
2. 300 3000.03 
3. 300 2997.98 
4. 300 2978.90 
5. 300 2996.34 
6. 300 3000.56 
 
Mean 
 
- 
2995.63 
 
Percentage Relative 
Standard Deviation 
 
- 
0.27 
 
Table – 15:  Repeatability studies for Paracetamol 
S.No Concentration (µg/ spot) Peak Area 
1. 30      27283.4 
2. 30 27224.6 
3. 30 27312.0 
4. 30 27313.7 
5. 30 27285.1 
6. 30 27275.4 
Mean - 27282.36 
Percentage Relative Standard 
Deviation 
- 0.11 
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Table – 16: Intra-day Precision of Ondansetron Hcl 
S. No Concentration 
(ng / spot) 
Area Mean Standard 
Deviation 
% RSD 
1. 
2. 
3. 
100 
100 
100 
910.2 
911.12 
913.45 
911.59 1.67 0.18 
1. 
2. 
3. 
300 
300 
300 
3000.0 
3000.09 
3008.13 
3002.74 4.66 0.15 
1. 
2. 
3. 
500 
500 
500 
4899.09 
4899.12 
4890.98 
4896.39 4.69 0.09 
 
Table – 17: Intra-day Precision of Paracetamol 
S. No Concentration 
(µg / spot) 
Area Mean Standard 
Deviation 
% RSD 
1. 
2. 
3. 
10 
10 
10 
8900.2 
     8900.7 
8932.09 
8910.99 18.26 0.20 
1. 
2. 
3. 
30 
30 
30 
27283.4 
27282.8 
27285.9 
27284.03 1.64 0.006 
1. 
2. 
3. 
50 
50 
50 
45210.9 
45200.08 
45211.98 
45207.65 6.58 0.01 
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Table – 18: Inter-day Precision of Ondansetron Hcl 
S. No Concentration 
(µng / spot) 
Area Mean Standard 
Deviation 
% RSD 
1. 
2. 
3. 
100 
100 
100 
899.5 
899.09 
898.89 
899.16 0.31 0.03 
1. 
2. 
3. 
300 
300 
300 
2989.09 
2988.77 
2987.67 
2988.51 0.74 0.02 
1. 
2. 
3. 
500 
500 
500 
4800.78 
4800.78 
4797.67 
4799.74 1.79 0.03 
 
Table – 19: Inter-day Precision of Paracetamol 
 
S. No Concentration 
(µg / spot) 
Area Mean Standard 
Deviation 
% RSD 
1. 
2. 
3. 
10 
10 
10 
8845.06 
8840.08 
8843.24 
8842.79 2.51 0.02 
1. 
2. 
3. 
30 
30 
30 
27200.67 
27203.90 
27211.78 
27205.45 5.71 0.02 
1. 
2. 
3. 
50 
50 
50 
45123.34 
45120.90 
45123.56 
45122.6  
1.47 
0.003 
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Table – 20 VALIDATION PARAMETERS 
 
Parameters Ondansetron Hcl  Paracetamol 
 
 
Linearity Range (µg/ml) 
100-500 ng/ml  10-50 µg/ml 
Concentration Peak 
area 
Concentration Peak 
area 
100 910.2 10 8900.2 
200 2008.7 20 17100.6 
300 3000.0 30 27283.4 
400 3844.3 40 36809.8 
500 4899.09 50 45210.9 
Coefficient Correlation 0.999 0.999 
Slope 9.781 905.9 
Y-intercept 0.80 0.35 
Rf 0.34 0.90 
Accuracy (% Recovery) 
(n = 3) %RSD 
 
1. 80 % 
 
2. 100% 
 
 
3. 120% 
 
 
 
   99.79%+0.02 
 
100.0%+0.07 
 
 
99.79%+0.02 
 
 
 
99.91%+0.71 
 
99.72%+0.59 
 
 
99.91%+0.71 
Precision (%RSD, n = 6) 
 
Intra-day( n = 3) (%RSD) 
 
Inter-day ( n = 3) (%RSD) 
0.27 
 
0.09-0.18 
 
0.02-0.03 
0.11 
 
0.006-0.20 
 
0.003-0.02 
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HPTLC CHROMATOGRAM OF SAMPLE OF ONDANSETRON 
HYDROCHLORIDE AND PARACETAMOL at UV 254 nm 
Chromatograms 
Before derivatization 
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ANALYSIS OF FORMULATION 
Twenty tablets (Brand name-Vomikind plus,manufactured by Mankind  Pharma) were taken 
and their average weight was determined. The Vomikind plus tablets were powdered into fine 
powder using Pestle and Mortar. 100  mg of drug samples was dissolved in methanol:water 
(90:10) ,centrifuged and the supernatant liquid was made-up to 10 ml in a volumetric flask 
with Methanol:water. This solution contains 10 µg tablet in µl Methanol:water used as test 
solution for quantitative analysis of Ondansetron Hcl and Paracetamol from Vomikind Plus 
tablet. 
 
From the peak area recorded the amount of the drug in the formulation was determined and 
reported in table no; 16 
 
 
Formulation Label Claim gm/tab Amount found 
gm/tab ± RSD 
% Assay  ± RSD 
Ondansetron 
Hcl 
0.0.040 0.399±0.0001 99.75±0.0001 
Paracetamol 0.500  501±0.200 100.20 ±0.200 
 
RSD for three Determinations 
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 Track S – Formulation Mixture Scanning baseline display @ 254nm 
 
 
 
Track S – Formulation Mixture Scanning Peak densitogram display @ 254nm 
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UV Spectrum of Ondansetron Hcl in Standards and Sample ( λ max – 309nm) 
 
 
 
UV Spectrum Of Paracetamol Hcl in Standards and Sample (λmax 252 nm) 
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RESULT & DISCUSSION 
UV SPECTROPHOTOMETRY 
               From the optical characteristics of the proposed methods, it was found that the λmax 
of Ondansetron Hcl and Promethazine Hcl was found to 310 nm and 250 nm. Ondansetron 
Hcl and Promethazine Hcl obey linearity within the concentration range of 5-25 µg/ml and 
10-50 µg/ml respectively from the result shown in table 3. The linearity was shown by 
calibration curve and the correlation coefficient (r2) values are 0.998 & 0.999 for 
Ondansetron Hcl and Promethazine Hcl respectively. Fig .12 & 13. From the table.1 .it was 
found that the %RSD is less than 2 % which indicates that the method has good reprocibility. 
The % recovery values of pure drug from the preanalyzed formulations were in between 99-
103 % indicates that the proposed method is accurate and reveals that the commonly used 
excipients and additives in formulations were not interpreting in proposed method. The 
results of validation parameters for the developed methods were reported in table.2. The 
analysis of formulation showed good result in concentration in range 98-101%.Table 4. 
Table 17 
Results on Application of UV-Spectroscopy 
Recovery 
Level 
Amt. of drug 
added (mg) 
Amt. of drug found 
(mg) 
Mean %  Recovery * 
+%RSD 
Ond 
Hcl 
Pro 
Hcl 
Ond Hcl  Pro Hcl Ond 
Hcl 
Pro 
Hcl 
Ond Hcl Pro Hcl 
Level 
1 
80%      3.2 20 3.18 20.21 3.2 20.08 100.0%+0.05 
 
100.40%+0.11 
3.19 20.07 
3.23 19.98 
Level 
2 
100% 4 25 4.04 24.90 4.01 25.03 100.25%+0.03 
 
100.12%+0.17 
4.01 25.23 
3.98 24.97 
Level 
3 
120% 4.8 30 4.81 29.97 4.80 30.03 100.1%+0.005 
 
99.91%+0.07 
4.80 30.02 
4.81 30.11 
 
RSD of three determinations 
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HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY 
                 During the stage of method development different mobile phase were tried and the 
mobile phase comprising of Dichlormethane : Methanol in the proportion of 9:1 v/v for 
Ondansetron Hcl and Paracetamol respectively were found to be better and produced the Rf 
value of  0.34 & 0.90 for Ondansetron Hcl and Paracetamol respectively. 
               The linearity of both the drugs were determined by calibration curves and the 
linearity based on the area observed in the range of 100-500ng/µl & 10-50µg/µl for 
Ondansetron Hcl and Paracetamol respectively. Table 6.Fig 14 & 15. 
              Recovery studies were carried out for the accuracy parameter and were reported in 
table 13. 
             The validation parameters like Calibration Range   100-500ng/µl & 10-50µg/µl for 
Ondansetron Hcl and Paracetamol. Simultaneously, Correlation co efficient (r2), 
Repeatability, are tabulated in table 12. 
           The validate method was applied for the analysis of the tablets containing 4 mg and 
500 mg mg of Ondansetron Hcl and Paracetamol respectively as label claim. An average 
quantity of  Ondansetron Hcl and Paracetamol were 498.65±0.59 and 4.0±0.09 respectively. 
          The results are tabulated in table 13. 
        The methods developed were simple. It has showed a good peak and good Rf values. 
The Proposed methods are specific,precise,accurate,and reproducible. Hence the proposed 
method can be used for the routine assay Ondansetron Hcl and Paracetamol. 
Results 
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RESULTS 
APPLICATION OF UV-SPECTROPHOTOMETRY FOR SIMULTANEOUS ESTIMATION 
 Instrument used- Elico SL 164  UV-VIS Spectrophotometer 
 
 Solvent selected-Chloroform 
 Wavelength used-310 nm for Ondansetron Hcl & 250 nm for Promethazine Hcl 
VALIDATION PARAMETERS 
Parameters Ondansetron Hcl  310 nm Promethazine Hcl  250nm Limit Pass/Fail 
Linearity Range(μg/ml) 5-25 µg/ml 10-50 µg/ml No limit Pass 
Coefficient of Correlation 0.998 0.999 NLT 0.999 Pass 
Precision (%RSD, n = 6) 
 
Intra-day( n = 3) (%RSD) 
 
Inter-day ( n = 3) (%RSD) 
0.39-1.47 
 
0.13-1.38 
 
0.22-0.96 
0.23-77 
 
0.29-1.08 
 
0.25-1.38 
 
 
RSD NMT 2% 
 
 
Pass 
Accuracy (% Recovery) 
 
80% 
100% 
120% 
 
  
100.0%+0.05 
100.25%+0.03 
100.1%+0.005 
 
 
 
 
100.40%+0.11 
100.12%+0.17 
99.91%+0.07 
 
 
 
97-103 % 
 
 
 
Pass 
Results 
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APPLICATION OF HPTLC IN ONDANSETRON HCL AND PARACETAMOL 
 Instrument Used-Camag 
 Mobile Phase- Dichloromethane :Methanol (9:1) 
 Run time-20 minutes 
 Wavelength used-254 nm 
VALIDATION PARAMETERS 
Parameters Ondansetron   Hcl Paracetamol Limits Pass/Fail 
Linearity Range(μg/ml) 100-500 ng/µl 10-50 µg/µl No limit Pass 
Coefficient of Correlation 0.999 0.999 NLT 0.999 Pass 
Precision (%RSD, n = 6) 
           Intra-day( n = 3) (%RSD) 
           Inter-day ( n = 3) (%RSD) 
0.27 
0.09 – 0.18 
0.02 – 0.03 
 
0.11 
0.006-0.20 
0.003-0.02 
 
 
RSD NMT 2% 
 
 
Pass 
Accuracy (% Recovery) (n = 3) %RSD 
80 % 
100% 
120% 
 
 
99.79%+0.02 
100.0%+0.07 
99.79%+0.02 
 
 
99.91%+0.71 
99.72%+0.59 
99.91%+0.71 
97-103 % Pass 
Rf Value 0.34 0.90 Less than 1 Pass 
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SUMMARY AND CONCLUSION 
                In order to develop a UV and HPTLC effective most of the effort should be spent in 
method development and optimization as this will improve the final method performance. A 
well developed should be easy to validate. A method should be developed with the goal to 
rapidly preclinical sample, formulation prototype and commercial samples. 
              Review of the literature on Ondansetron Hcl and Promethazine Hcl & Ondansetron 
and Paracetamol strongly indicates that there is no method available for UV and HPTLC 
method for Simultaneous determination and validation of Ondansetron Hcl and Promethazine 
Hcl & Ondansetron Hcl and Paracetaml in bulk and pharmaceutical dosage forms,but 
individual and combination with other drugs methods are available. 
              
¾ The analytical procedure described for assay represents a 
specific,linear,precise,accurate and system suitable for Simultaneous determination of 
Ondansetron Hcl and Promethazine Hcl by UV-Spectroscopy and Ondansetron Hcl 
and Paracetamol by HPTLC in bulk and pharmaceutical dosage form. 
¾ By observing the validation parameters,accuracy,precision,expressed as % 
RSD,specificity,linearity (correlation –coefficient). The validation methods can be 
employed for routine analysis of bulk and formulation for assay. 
¾ The formulations were successfully analyzed using the developed methods. 
¾ The results obtained from the validation parameters met the ICH,FDA and USP 
requirements as well as obeys Beer’s law. 
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